News

ImmunityBio, a privately-held immunotherapy company, announced the results of a highly detailed computer-based molecular dynamics (MD) simulation, conducted in collaboration with…
Read More...

aTyr Pharma, Inc. a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, announced positive topline results from…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that Israel’s Ministry of Health (MOH) has given authorization to import the…
Read More...

Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to utilize Insilico's novel generative artificial intelligence (AI)…
Read More...

Incyte and Cellenkos, Inc., a privately held, clinical stage biotech company,  announced a development collaboration to investigate the combination of ruxolitinib (Jakafi) and CK0804,…
Read More...

Biogen Inc. and Sage Therapeutics, Inc. announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for…
Read More...

BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced an agreement to supply Mainland China with an initial 100 million doses of their BNT162 mRNA-based vaccine…
Read More...

Novartis has entered an agreement to acquire Cadent Therapeutics, a Cambridge, Massachusetts based neuroscience company. The acquisition adds two new clinical stage programs to the…
Read More...

Two randomized, controlled Phase 3 clinical trials have begun evaluating investigational monoclonal antibodies for their safety and efficacy in treating people hospitalized with…
Read More...

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, confirmed that the…
Read More...

Ultragenyx Pharmaceutical Inc. a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare diseases, and Mereo…
Read More...

GlaxoSmithKline plc announced the US Food and Drug Administration (FDA) has approved BENLYSTA (belimumab) for the treatment of adult patients with active lupus nephritis (LN) who are…
Read More...

Novartis announced that the U.S. Food and Drug Administration (FDA) granted iptacopan (LNP023) Breakthrough Therapy Designation (BTD) in paroxysmal nocturnal hemoglobinuria (PNH) and…
Read More...

Genosity, Inc, a biotechnology company offering novel software and laboratory solutions to enable development and deployment of complex NGS assays, announced an agreement with Gemini…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 12 to 1 that the data presented support the use of…
Read More...

M.S.Q. Ventures is pleased to announce that its client, ADC Therapeutics SA, has successfully entered into an agreement to jointly form a new company, Overland ADCT BioPharma (CY)…
Read More...

vTv Therapeutics Inc. announced that vTv Therapeutics LLC (“vTv”) has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2…
Read More...

Salesforce, the global leader in CRM, and Gavi, the Vaccine Alliance, announced that they will collaborate to help Gavi manage critical information to equitably distribute approximately…
Read More...

Eli Lilly and Company and Prevail Therapeutics Inc. announced a definitive agreement for Lilly to acquire Prevail for $22.50 per share in cash (or an aggregate of approximately $880…
Read More...

Novartis announced positive findings from the first interpretable results of the Phase III KESTREL study, assessing the efficacy and safety of Beovu (brolucizumab) 3 mg and 6 mg in…
Read More...